Dr. Azza Gadir is a molecular immunologist with experience in the field of immune tolerance. Azza previously served as Director of Research and Development at Seed Health overseeing pre-clinical research, regulatory, clinical trials, and academic collaborations.
Azza completed her postdoctoral training at Harvard Medical School (Boston Childrens' Hospital) where her published research was focused on the immunological mechanisms that underlie the role of the gut microbiome in conferring protection from diseases early in life. For this work, she holds issued and pending patents and has collaborated with industry partners to accelerate the discovery of microbiome-related immunotherapies for food allergy.
Azza grew up in London and holds a Ph.D. in Immunology from University College London (UK), an M.Sc. in the Immunology of Infectious Diseases from the London School of Hygiene and Tropical Medicine (UK), and a B.Sc. in Biochemistry from King's College London (UK).